Repaglinide is used to help lower blood sugar levels in people with type 2 diabetes. It causes the pancreas to make more insulin in order to lower blood sugar levels after meals. The medication, which comes in tablet form, is typically taken up to half an hour before each meal. Potential side effects of repaglinide include headaches, low blood sugar levels, and upper respiratory tract infections.
Repaglinide (
Prandin®) is a prescription medication that is used to treat
type 2 diabetes (also known as non-insulin-dependent
diabetes or adult-onset diabetes).
Repaglinide is manufactured by Novo Nordisk, Inc.
How Does Repaglinide Work?
Repaglinide is part of a group of diabetes medications called meglitinides. Meglitinides help the
pancreas make more insulin, which helps to lower blood sugar. Another type of
diabetes medication, called sulfonylureas, also helps the pancreas make more insulin. However, unlike sulfonylureas, repaglinide is short-acting and is used to lower blood sugar after meals.
Several studies have looked at the effects of repaglinide, particularly with regards to hemoglobin A1c and postprandial blood sugar levels.
Add this article to your Favorites
Email this article
Print